Grand Challenges in Global Mental Health: Complete Study Guide

Overview of the Grand Challenges in Global Mental Health

Definition of MNS Disorders: Mental, neurological, and substance-use (MNS) disorders.
Global Burden: MNS disorders constitute $13\%$ of the global burden of disease, which surpasses the burden resulting from both cardiovascular disease and cancer.
Specific Disease Statistics:
- Depression: The third leading contributor to the global disease burden.
- Alcohol and Drug Use: Account for more than $5\%$ of the global disease burden.
- Dementia: A new case develops every $7$ seconds. In 2009, the global cost of dementia was estimated at up to $US\$609\,billion$ .
- Suicide: By 2020, an estimated $1.5\,million$ people will die by suicide annually, with between $15\,million$ and $30\,million$ individuals making the attempt.
Research and Treatment Gaps:
- There is a dearth of preventive interventions and cures due to limited understanding of the molecular and cellular mechanisms of the brain.
- Access Disparities: In $83\%$ of low-income countries, anti-Parkinsonian treatments are unavailable in primary care; in $25\%$ , there are no anti-epileptic drugs.
- Human Resource Inequality: The World Health Organization (WHO) European region has $200$ times as many psychiatrists as the African region.
- Funding Imbalance: Investment in fundamental research for MNS disorders is disproportionately low compared to the disease burden.

The Grand Challenges Initiative Framework

Founding Organizations: funded by the US National Institute of Mental Health (NIMH) and supported by the Global Alliance for Chronic Diseases (GACD).
Scope and Exclusions: The initiative focuses on MNS disorders but excludes conditions with vascular or infectious aetiology (e.g., stroke or cerebral malaria), as these were covered in previous grand challenges.
Distinguishing Features:
- Global Scale: The scope is truly international rather than regional.
- Delphi Method: Uses a structured technique with controlled feedback to reach consensus among a large, dispersed panel.
- Comprehensive Coverage: Includes the full range of MNS disorders.
- Community Building: Aims to establish a wide-ranging community of research funders.

The Delphi Prioritization Process

Organizational Structure:
- Executive Committee: Leaders of key funding agencies providing oversight.
- Scientific Advisory Board: Disciplined scientific leaders guiding the process.
- Administrative Team: NIMH staff coordinating data and communication.
The Panel: 594 individuals were nominated (researchers, advocates, clinicians, implementers); 422 participants from over $60$ countries took part.
- Composition: Approximately $1/3$ in genetics, neuroscience, and basic behavioral science; $1/4$ in mental-health services research; and $1/3$ in clinical research and epidemiology.
The Three Rounds:
- Round 1: Panelists identified "grand challenges," defined as specific barriers that, if removed, would solve an important health problem with feasible scaling potential. This yielded $1,565$ challenges.
- Round 2: The list was distilled to $154$ unique challenges; panelists identified their top $40$ .
- Round 3: Panelists ranked the top challenges on a four-point scale based on:
  1. Ability to reduce disease burden.
  2. Impact on equity.
  3. Immediacy of impact.
  4. Feasibility.

Core Summary Principles

Life-Course Approach: Studying disorders from early fetal development through old age, recognizing that many manifest early in life.
System-Wide Approaches: Addressing the suffering of families and communities, focusing on social exclusion and discrimination.
Evidence-Based Interventions: Ensuring all treatments (psychosocial or pharmacological) are supported by rigorous data.
Environmental Influences: Understanding the role of poverty, war, and natural disasters on mental health outcomes.
Mental Capital: Building cognitive and emotional resources to enhance an individual's ability to contribute to society and maintain quality of life.

Master List of Grand Challenges and Research Goals

Goal A: Identify Root Causes, Risk, and Protective Factors

Identify Modifiable Factors: Social and biological risk factors across the life course.
Environmental Impact: Understand how poverty, violence, war, migration, and disaster affect MNS disorders.
Biomarkers: Identify specific biological markers for disorders.
Specific Research Questions:
- Relationships between fetal/child development and MNS onset.
- Phenotypes and endophenotypes across diverse cultural settings.
- Gene-environment interactions increasing risk.
- Resilience factors in persons at extreme social disadvantage.

Goal B: Advance Prevention and Implementation of Early Interventions

Community Support: Create environments that promote well-being throughout life.
Duration of Illness: Develop culturally sensitive early interventions to reduce the time an illness goes untreated.
Socioeconomic Status: Interventions to mitigate the negative impact of low childhood SES on cognitive ability.
Primary Prevention: Develop evidence-based sets of interventions for various MNS disorders.
Child Protection: Strategies to eliminate childhood abuse.
Specific Research Questions:
- Behavioral skills to enhance executive function and cognitive flexibility.
- Neuroprotective agents or cognitive retraining during rapid brain development.
- Effectiveness of home- and school-based child abuse interventions.

Goal C: Improve Treatments and Expand Access to Care

Primary Care Integration: Incorporate screening and service packages into routine health care.
Medication Supply: Reduce costs and improve the availability of effective medications.
Task Shifting: Develop treatments for use by lay health workers and non-specialists.
Technology Utilization: Use mobile and IT technologies (telemedicine) for evidence-based care.
Specific Research Questions:
- Efficiency of brief screening tools in routine care.
- Outcomes of serious mental disorder treatments delivered by lay workers.
- Using mobile technology to monitor seizures or video games for cognitive remediation.

Goal D: Raise Awareness of the Global Burden

Stigma and Discrimination: Develop culturally informed methods to eliminate social exclusion.
Data Standardization: Establish shared global systems for surveillance, prevalence, and human resource availability.
Specific Research Questions:
- Components of effective anti-stigma interventions.
- Impact of macroeconomic factors (unemployment, trade) on MNS prevalence.
- Measurement factors contributing to prevalence differences across ethnic groups.

Goal E: Build Human Resource Capacity

Regional Centers: Establish centers for research and training in low- and middle-income countries (LMICs).
Diverse Providers: Sustainable models for training culturally diverse lay and specialist providers.
General Training: Strengthen mental-health training for all healthcare personnel.
Specific Research Questions:
- Most effective ways to train primary care workers to maintain fidelity to guidelines.
- Comparative effectiveness of care between different cadres of providers.

Goal F: Transform Health-System and Policy Responses

Minimum Standards: Implement global health-care standards for MNS disorders.
Parity: Redesign systems to integrate MNS care with chronic-disease care, creating parity with physical illness.
International Aid: Incorporate mental health into international development programs.

Global Burden Rankings (Table 1 Data)

Disability-Adjusted Life Year (DALY): A unit measuring health lost due to disease or injury, calculated as the present value of future years of disability-free life lost.

Worldwide Rank of MNS Disorders (by DALYs in millions)

Unipolar Depressive Disorders: $65.5$
Alcohol-use Disorders: $23.7$
Schizophrenia: $16.8$
Bipolar Affective Disorder: $14.4$
Alzheimer’s and Other Dementias: $11.2$
Drug-use Disorders: $8.4$
Epilepsy: $7.9$
Migraine: $7.8$
Panic Disorder: $7.0$
Obsessive-Compulsive Disorder: $5.1$

Income-Based Variations (Top 3 Causes)

High-Income Countries:
1. Unipolar depressive disorders ( $10.0\,million$ DALYs)
2. Alzheimer’s and other dementias ( $4.4\,million$ DALYs)
3. Alcohol-use disorders ( $4.2\,million$ DALYs)
Low- and Middle-Income Countries:
1. Unipolar depressive disorders ( $55.5\,million$ DALYs)
2. Alcohol-use disorders ( $19.5\,million$ DALYs)
3. Schizophrenia ( $15.2\,million$ DALYs)

Actionable Next Steps

Investment: Action requires immediate and long-term funding; progress is possible within a $10$ -year window if started now.
Collaborative Hubs: The NIMH has already committed to "Collaborative Hubs for International Research in Mental Health" to support non-specialist care and training in LMICs.
Stakeholder Engagement: The WHO should disseminate these challenges to health ministries. Other involved parties should include the World Bank, regional development banks, and the global business community.
Monitoring: Leadership from the Grand Challenges and GACD planned to meet in October 2011 to develop a strategy for monitoring progress.
Economic Benefit: Addressing these challenges will lead to increased productivity and reduced inappropriate health-care use, outweighing investment costs.